Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in Lesotho

NCT ID: NCT03630549

Last Updated: 2021-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

257 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-08-16

Study Completion Date

2020-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cluster-randomized trial tests a differentiated care model for HIV-positive individuals not on ART during a home-based HIV testing campaign in rural Lesotho, Southern Africa. In intervention clusters, patients are offered a differentiated ART delivery package with two features. Firstly, drug-refill and follow-up are provided by village health workers (VHW), reducing clinic visits to twice a year for laboratory assessment. Secondly, participants have the option of receiving individually tailored adherence reminders and viral load result notifications via SMS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The VIBRA trial is a cluster randomized controlled, open-label, superiority trial in a resource-limited setting. The trial is linked to a another trial, the HOSENG (HOme-based SElf-testiNG) trial, that is described elsewhere (NCT03598686). Together, they consitute the GET ON (GETing tOwards Ninety) research project. The HOSENG study, with its home-based HIV testing campaign, provides the recruitment platform for the VIBRA study. The reasons for this interlinked design are: a) potential study participants for VIBRA trial (HIV-positive individuals not on ART) are to be recruited during a home-based HIV testing campaign and hence, it allows us to assess the entire HIV care cascade in one larger project, and b) both trials rely on interventions involving VHWs, who need to be randomized and specifically trained. Therefore, it is efficient and feasible to run both trials parallel and randomize at one time point only. The rational for a cluster randomized design is the reliance of the trial on the VHWs and, thus, the high risk of cross-contamination between the study arms if randomization would be done at individual level.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV/AIDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel cluster-randomized
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of Care

1. Offer of home-based same-day ART initiation
2. Clinic-based ART visit/refill Who: Nurse Where: Nurse-led health facility When: Follow-up interval of max. 3 months What: TB screening, Screening for other opportunistic infections, Screening for ART-related toxicities, adherence assessment, assessment whether patient visited any medical facility since last appointment, addressing basic psychosocial problems, ART (+CTX/IPT) dispensing
3. No SMS intervention

Group Type ACTIVE_COMPARATOR

Standard of Care

Intervention Type OTHER

Clinic-based HIV care

Village-based ART refill

1. Offer of home-based same-day ART initiation
2. Offer of Village-based ART visit/refill Who: VHW Where: At VHW's home\* When: Follow-up interval of max. 3 months What: TB screening, Screening for other opportunistic infections, Screening for ART-related toxicities, adherence assessment, assessment whether patient visited any medical facility since last appointment, addressing basic psychosocial problems, ART (+CTX/IPT) dispensing

\*Except at 6 and 12 months follow-up: visit at health facility for laboratory assessment (viral load)
3. Offer of Individually customized SMS

* Monthly reminder SMS: to pick up ART
* SMS communicating VL result

Group Type EXPERIMENTAL

Village-based ART refill

Intervention Type OTHER

Option to get ART refill and care by the village health worker

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard of Care

Clinic-based HIV care

Intervention Type OTHER

Village-based ART refill

Option to get ART refill and care by the village health worker

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VIBRA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* the cluster is clearly confined to the catchment area of one of the study clinics
* the cluster has at least one registered VHW who is willing to participate and fulfills the following criteria:
* is at least 18 years of age
* has adequate reading and writing skills
* successfully passes the training assessment
* village authority (village chief) is willing to participate in trial


* Individual is a household member of the visited households of the respective clusters
* Individual is confirmed HIV-positive
* Individual has never taken ART (ART-naïve) or has stopped ART more than 30 days prior (ART-defaulters)
* Individual is ≥10 years old and has a body weight of ≥35kg
* Individual is not in care for high blood pressure or diabetes (high blood sugar)
* HIV-positive individual wishes to get care outside the study districts

Exclusion Criteria

* Village authority (=village chief) opposed to trial participation (verbal assent)
* Village health worker opposed to trial participation or not fulfilling the minimum requirements mentioned above


* The household member is absent at the time of the campaign
* HIV-positive individual is taking ART or stopped less than 30 days ago
* HIV-positive individual is physically, mentally, or emotionally not able to participate in the study, in the opinion of the investigators or study staff
* HIV-positive individual is in care for high blood pressure (hypertension) or high blood sugar (diabetes) - proof of documentation or medication needed
* HIV-positive individual wishes to get care outside the study districts
Minimum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, Lesotho

OTHER_GOV

Sponsor Role collaborator

SolidarMed

OTHER

Sponsor Role collaborator

University of Basel

OTHER

Sponsor Role collaborator

University Hospital, Basel, Switzerland

OTHER

Sponsor Role collaborator

Niklaus Labhardt

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Niklaus Labhardt

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Niklaus D Labhardt, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Basel & Swiss Tropical and Public Health Institute

Tracy R Glass, PhD

Role: STUDY_CHAIR

Swiss Tropical & Public Health Institute

Manuel Battegay, MD

Role: STUDY_CHAIR

University Hospital, Basel, Switzerland

Josephine Muhairwe, MD

Role: STUDY_CHAIR

SolidarMed - Swiss Organization for Health in Africa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

District of Butha-Buthe

Butha-Buthe, , Lesotho

Site Status

District of Mokhotlong

Mokhotlong, , Lesotho

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lesotho

References

Explore related publications, articles, or registry entries linked to this study.

Amstutz A, Lejone TI, Khesa L, Kopo M, Kao M, Muhairwe J, Bresser M, Raber F, Klimkait T, Battegay M, Glass TR, Labhardt ND. Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial. PLoS Med. 2021 Oct 21;18(10):e1003839. doi: 10.1371/journal.pmed.1003839. eCollection 2021 Oct.

Reference Type DERIVED
PMID: 34673765 (View on PubMed)

Amstutz A, Lejone TI, Khesa L, Muhairwe J, Nsakala BL, Tlali K, Bresser M, Tediosi F, Kopo M, Kao M, Klimkait T, Battegay M, Glass TR, Labhardt ND. VIBRA trial - Effect of village-based refill of ART following home-based same-day ART initiation vs clinic-based ART refill on viral suppression among individuals living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho. Trials. 2019 Aug 22;20(1):522. doi: 10.1186/s13063-019-3510-5.

Reference Type DERIVED
PMID: 31439004 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan: Protocol V6 approved by Ethics Board on May 30, 2018

View Document

Document Type: Study Protocol and Statistical Analysis Plan: Amended Protocol V7 approved by Ethics Board on Oct 9, 2018

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://getonproject.wordpress.com

Official Project Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VIBRA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.